ArticleIntestinal research2018
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.
Abstract read
In one paragraph
Article in Intestinal research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Partial Enteral Nutrition in the Management of Crohn's Disease: A Systematic Review and Meta-Analysis.Journal of Crohn's & colitis · 2025Pooled it
- Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis.Journal of gastroenterology · 2020Pooled it
- Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial.United European gastroenterology journal · 2025Trial
- Plant and Animal Protein Sources in Inflammatory Bowel Disease: Current Evidence and Clinical Implications.JGH open : an open access journal of gastroenterology and hepatology · 2026Review
- Patient Acceptability of Partial Enteral Nutrition as a Concomitant Therapy to Adalimumab in Adults with Active Crohn's Disease: BIOPIC Trial.Annals of nutrition & metabolism · 2026Article
- Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions.Nutrients · 2025Review
- The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn's disease: a cohort study.Frontiers in nutrition · 2025Article
- Patient experiences with and adherence to Crohn's disease exclusion diet in Dutch Crohn's disease patients: a cohort study.Therapeutic advances in gastroenterology · 2025Article
- Role of diet in prevention versus treatment of Crohn's disease and ulcerative colitis.Frontline gastroenterology · 2024Review
- Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice.International journal of molecular sciences · 2024Article
- Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024Article
- Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease.Nutrients · 2021Review
- Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease.Intestinal research · 2021Article
- Nutritional Aspects of Pediatric Gastrointestinal Diseases.Nutrients · 2021Review
- Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.Journal of gastroenterology · 2021Review
- Diet and nutrition in the management of inflammatory bowel disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021Review
- Nutritional Therapy Strategies in Pediatric Crohn's Disease.Nutrients · 2021Review
- Fool me once… treatment exposure to achieve remission in pediatric IBD.European journal of pediatrics · 2020Article
- Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn's disease: the Indian experience.Intestinal research · 2020Article
- Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow.Intestinal research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Tadakazu HisamatsuThe Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan.
Reiko KunisakiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Shiro NakamuraDepartment of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Japan.
Tomoyuki TsujikawaDepartment of Gastroenterology and Hepatology, National Hospital Organization, Higashi-Ohmi Medical Center, Higashi-Ohmi, Japan.
Fumihito HiraiDepartment of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
Hiroshi NakaseDepartment of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kenji WatanabeDivision of Gastroenterology, Osaka City General Hospital, Osaka, Japan.
Kaoru YokoyamaDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Masakazu NagahoriDepartment of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Takanori KanaiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Makoto NaganumaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Hirofumi MichimaeDepartment of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
Akira AndohDivision of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.
Akihiro YamadaDepartment of Internal Medicine, Toho University Sakura Medical Centre, Sakura, Japan.
Tadashi YokoyamaYokoyama IBD Clinic, Aichi, Japan.
Noriko KamataDepartment of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yasuo SuzukiDepartment of Internal Medicine, Toho University Sakura Medical Centre, Sakura, Japan.
Toshifumi HibiCenter for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Mamoru WatanabeDepartment of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
CERISIER Trial group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.